Braxia Scientific Corp.
BRAX
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 362.00K | 442.90K | 446.80K | 386.30K | 360.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 362.00K | 442.90K | 446.80K | 386.30K | 360.20K |
| Cost of Revenue | 301.70K | 346.70K | 381.50K | 367.50K | 353.00K |
| Gross Profit | 60.30K | 96.20K | 65.30K | 18.70K | 7.20K |
| SG&A Expenses | 636.00K | 180.70K | 518.50K | 1.56M | 1.57M |
| Depreciation & Amortization | 54.30K | 54.70K | 41.80K | 119.80K | 139.90K |
| Other Operating Expenses | -- | -- | 3.10K | -100.00 | -- |
| Total Operating Expenses | 992.00K | 582.10K | 959.10K | 2.05M | 2.12M |
| Operating Income | -630.00K | -139.20K | -512.30K | -1.66M | -1.76M |
| Income Before Tax | -666.70K | -203.40K | -597.20K | -5.77M | -1.60M |
| Income Tax Expenses | -- | -- | -- | -107.90K | -- |
| Earnings from Continuing Operations | -666.70K | -203.40K | -597.20K | -5.66M | -1.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -666.70K | -203.40K | -597.20K | -5.66M | -1.60M |
| EBIT | -630.00K | -139.20K | -512.30K | -1.66M | -1.76M |
| EBITDA | -595.00K | -104.00K | -478.00K | -1.55M | -1.62M |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.02 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 263.71M | 263.71M | 263.71M | 248.52M | 240.72M |
| Average Diluted Shares Outstanding | 263.71M | 263.71M | 263.71M | 248.52M | 240.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
